You are here

Article Text

Article menu
Download PDFPDF
PostScript
Authors' response
  1. B Åsling1,
  2. J Jirholt1,
  3. P Hammond2,
  4. M Knutsson1,
  5. A Walentinsson1,
  6. G Davidson2,
  7. L Agreus3,
  8. A Lehmann1,
  9. M Lagerström-Fermer1
  1. 1AstraZeneca R&D, Mölndal, Sweden
  2. 2Women's & Children's Hospital, Gastroenterology Unit, North Adelaide, South Australia, Australia
  3. 3Center for Family and Community Medicine, Karolinska Institutet, Huddinge, Sweden
  1. Correspondence to Dr B Åsling, AstraZeneca R&D, Pepparedsleden 1, S-431 83 Mölndal, Sweden; bengt.asling{at}astrazeneca.com

https://doi.org/10.1136/gut.2009.197806

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We sincerely appreciate the interest in our recent paper in Gut entitled “Collagen type III (COL3A1) is a gastro-oesophageal reflux disease (GORD) susceptibility gene and a male risk factor for hiatus hernia”.1 The diagnosis of hiatal hernia requires endoscopy, a barium meal and/or manometric assessment.2 Histology is not required for …

    View Full Text

    Footnotes

    • Linked articles 188086.

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles